Targeted Therapy of the XIAP/proteasome Pathway Overcomes TRAIL-resistance in Carcinoma by Switching Apoptosis Signaling to a Bax/Bak-Independent ‘Type I’ Mode

Cell Death and Disease - United Kingdom
doi 10.1038/cddis.2013.67